NYSE: DNA - Ginkgo Bioworks Holdings, Inc.

Yield per half year: -37.57%
Sector: Healthcare

Current price
8.74 $
Average price
15.1 $ +72.8%

Price based on EPS
94.4 $ +980.07%
10/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 94.4 $
Current price = 8.74 $ (difference = +980.07%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -14.33 $
Current price = 8.74 $ (difference = -263.99%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -4.81 $
Current price = 8.74 $ (difference = -154.98%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription